Sensei Biotherapeutics(SNSE.US)

Last Updated 19:00:00 ET
longbridge loading

Sensei Biotherapeutics (NASDAQ:SNSE) Major Shareholder Millennium Management Llc Sells 8,151 Shares

Market Beat·
US
SNSE
+0.85%
Market Beat·
US
SNSE
+0.85%

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga_article·
US
ARAY
-7.81%
US
SNSE
+0.85%
US
SBFM
+40.68%
benzinga_article·
US
ARAY
-7.81%
US
SNSE
+0.85%
US
SBFM
+40.68%

Sensei Biotherapeutics reports $170.2M Q1 net loss, $202.8M cash position

TradingView·
US
SNSE
+0.85%
US
FBT
+1.05%
US
LABU
+2.11%
TradingView·
US
SNSE
+0.85%
US
FBT
+1.05%
US
LABU
+2.11%

Sensei Biotherapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
SNSE
+0.85%
Earnings Watch·
US
SNSE
+0.85%

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | SNSE Stock News

StockTitan·
US
SNSE
+0.85%
US
BBH
+0.72%
US
ARKG
+2.54%
StockTitan·
US
SNSE
+0.85%
US
BBH
+0.72%
US
ARKG
+2.54%

03:40 ETSenhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination

prnewswire·
US
SNSE
+0.85%
US
BGNE
0.00%
US
ONC
+0.22%
prnewswire·
US
SNSE
+0.85%
US
BGNE
0.00%
US
ONC
+0.22%

Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data for Lead Candidate Targeting Infected Diabetic Foot Ulcers | LABT Stock News

StockTitan·
US
ATRA
-0.21%
US
SNSE
+0.85%
US
LSB
0.00%
StockTitan·
US
ATRA
-0.21%
US
SNSE
+0.85%
US
LSB
0.00%

Sensei appoints Stephen M. Hahn, Saira Ramasastry and Karen Vousden as directors; Christopher W. Gerry, Thomas Ricks and Kristian Humer to resign

TradingView·
US
SNSE
+0.85%
US
SBIO
+1.83%
US
PBE
+0.67%
TradingView·
US
SNSE
+0.85%
US
SBIO
+1.83%
US
PBE
+0.67%
© 2026 Longbridge｜Disclaimer